Yongin-si, South Korea

Jung-Soon Yoon


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jung-Soon Yoon in Influenza Vaccine Development

Introduction

Jung-Soon Yoon is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of immunology, particularly in the development of vaccines against influenza viruses. His innovative work focuses on creating a universal influenza vaccine that can provide broad protection against various strains of the virus.

Latest Patents

Jung-Soon Yoon holds a patent for a groundbreaking invention titled "Influenza T-cell immunization against diverse influenza A viruses." This patent describes a T cell-based universal influenza vaccine that includes internal genes capable of preparing against infection by broad hetero-subtypic influenza viruses. The invention aims to address the challenges posed by unpredictable epidemic influenza by selecting internal genes from consensus sequences obtained from bird, pig, and human influenza isolates. The vaccine is characterized by including at least one CTL epitope and utilizing the entire sequence of the internal gene itself. This innovative approach allows for broad defense against infections caused by hetero-subtypic influenza viruses.

Career Highlights

Jung-Soon Yoon is affiliated with the Mogam Biotechnology Research Institute, where he continues to advance his research in vaccine development. His work is pivotal in the ongoing efforts to combat influenza, a virus that poses significant public health challenges worldwide.

Collaborations

Some of his notable coworkers include Jin-Won Youn and Ji-Sun Kwon, who contribute to the collaborative research environment at the Mogam Biotechnology Research Institute.

Conclusion

Jung-Soon Yoon's innovative contributions to the field of influenza vaccine development highlight the importance of research in combating viral infections. His work on a T cell-based universal influenza vaccine represents a significant advancement in immunology and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…